MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

    A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of this study was to validate the new diagnostic criteria for fatigue1 in Parkinson’s disease patients. Background: Case definition and diagnostic criteria…
  • 2018 International Congress

    Circadian modifications in Parkinson disease

    S. Guo (Wuhan, China)

    Objective: To observe the expression of circadian rhythm related genes Bmal1 and melatonin receptors in different brain regions of 6-OHDA-induced acute Parkinson's disease rats. Background:…
  • 2018 International Congress

    Sexual Dysfunction in Women with Parkinson’s Disease

    A. Hannoun, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To assess the prevalence and severity of sexual dysfunction (SD) in women with Parkinson’s Disease (PD) in comparison to general population (GP), highlight the…
  • 2018 International Congress

    Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP): Results of the SIAXI study

    W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, F. Pagan, B. Flatau-Baqué, J. Csikós, A. Blitzer (Wolfach, Germany)

    Objective: The pivotal double-blind, randomised Phase III SIAXI study (NCT02091739), assessed the efficacy and safety of incobotulinumtoxinA 75 or 100 U for sialorrhea. Co-primary endpoints…
  • 2018 International Congress

    The phenomenology of visual hallucinations in Parkinson’s disease: A descriptive analysis of Myanmar and Thai patients

    Z. Shwe, J. Sringean, E. The, W. Thit, R. Bhidayasiri (Yangon, Myanmar)

    Objective: To describe the phenomenology of visual hallucinations in Myanmar and Thai PD patients. Background: Visual hallucinations are frequently reported by Parkinson’s disease (PD) patients,…
  • 2018 International Congress

    Total CSF alpha-synuclein is inversely associated with non-motor symptoms in a population of patients with Parkinson’s Disease

    T. Schirinzi, G. Sancesario, G. Di Lazzaro, B. Biticchi, N. Mercuri, S. Bernardini, A. Pisani (Rome, Italy)

    Objective: To evaluate the association between PD non-motor symptoms (NMS) and CSF levels of neurodegeneration-related proteins in a population of PD patients, aimed at identifying…
  • 2018 International Congress

    Effect of CDNF on non-motor symptoms like motivation, fear, stress and depression-like behavior

    P. Stepanova, M. Voutilainen, E. Laakkonen, M. Airavaara, V. Voikar, P. Piepponen, R. Tuominen, M. Saarma (Helsinki, Finland)

    Objective: The goal of this study was to characterize the effect of CDNF on motivation, stress and depression-like behavior, because most of the non-motor symptoms,…
  • 2018 International Congress

    Non-Motor Symptom In Young Onset Parkinson Disease as a Cause of Pharmacoresistence In Epilepsy

    M. Awadh (Birmingham, United Kingdom)

    Objective: To report an interesting initial presentation of PD causing refractory epilepsy. Background: A lady with refractory depression, presented with first seizure at age 42,…
  • 2018 International Congress

    Predictors and biomarkers of pain in newly diagnosed Parkinson’s disease patients during a two-year follow-up

    S. Perez-Lloret, A. Sauerbier, C. Falup-Percurariu, M. Tinazzi, K.R. Chaudhuri (Buenos Aires, Argentina)

    Objective: To identify clinical characteristics, predictors and biomarkers of pain at baseline and after a two-year follow-up period in newly diagnosed drug-naïve Parkinson's Disease (PD)…
  • « Previous Page
  • 1
  • …
  • 1549
  • 1550
  • 1551
  • 1552
  • 1553
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley